grafting
-
Top Stories
Biogennix’s DirectCell Advanced Bone Grafting System Used in 1000th Case
IRVINE, Calif. – November 29, 2022 /OrthoSpineNews/ – Irvine-based Biogennix, a market leader in advanced bone regeneration technology, announced today…
Read More » -
Biologics
Biogennix’s DirectCell Advanced Bone Grafting System Used in 500th Case
IRVINE, Calif. – May 17, 2022 / OrthoSpineNews / – Irvine-based Biogennix, a market leader in advanced bone regeneration technology,…
Read More » -
Biologics
Royal Biologics announces U.S. commercial launch of Advanced-Cell™, an advanced bone grafting and fusion convenience kit.
April 26, 2022 /OrthoSpineNews/ – Royal Biologics (Hackensack, NJ) a company specializing in Advanced Cellular & Autologous Technologies for Enhanced Healing today…
Read More » -
Biologics
Biogennix Launches Agilon Strip Advanced Bone Grafting Solution
IRVINE, Calif. — April 14, 2021 — Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft…
Read More » -
Biologics
Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable Bone Grafting Solution in Spine Procedures
March 04, 2020 IRVINE, Calif.–(BUSINESS WIRE)–Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for…
Read More » -
Biologics
Biogennix Launches Agilon Bone Grafting Solution
September 04, 2019 IRVINE, Calif.–(BUSINESS WIRE)–Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for…
Read More » -
Biologics
Vivorté announces the commercial availability of FORTERA™ and REGENTO™ bone grafting solutions for orthopedic surgery
LOUISVILLE, KY — (October 3, 2017) — Vivorté, Inc., a vertically-integrated, specialty orthopedic biomaterials company, today announced the commercial availability of…
Read More »